🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
The primary objective was to evaluate the persistence of bactericidal antib...
Status
Completed
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Start Date
2010-07
Trial ID
NCT01148017
Treatments Being Tested
The purpose/aim of this study is to assess the safety and antibody response...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-08
Trial ID
NCT02986854
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
This safety surveillance study of GlaxoSmithKline's quadrivalent meningococ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-01
Trial ID
NCT02287688
Treatments Being Tested
This study compares the safety and immunogenicity profile of several travel...
Status
Completed
Location
Centrum ockovani a cestovni mediciny (Vaccination and Travel Medicine Centre) Poliklinika II
Start Date
2011-11
Trial ID
NCT01466387
The purpose of this study is to evaluate the safety, immunogenicity and ind...
Status
Completed
Location
Vaccine Evaluation Center
Start Date
2004-09
Trial ID
NCT00262002
Treatments Being Tested
The primary objective is to evaluate the persistence of bactericidal antibo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01018732
Treatments Being Tested
This study was designed to conduct a comparative trial to further evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-07
Trial ID
NCT01682876
Treatments Being Tested
The purpose of the study was to assess the immunogenicity and safety of two...
Status
Completed
Location
06 Kosin University Gospel Hospital 34, amnam-dong
Start Date
2013-11
Trial ID
NCT01973218